Zobrazeno 1 - 10
of 32
pro vyhledávání: '"R. Shigarminova"'
Autor:
Orbetzova M, E. Nachev, I. Atanassova, R. Shigarminova, Georgi Kirilov, Krassimir Kalinov, Sabina Zacharieva
Publikováno v:
Hormone and Metabolic Research. 37:36-39
Background: There are limited data regarding the role of vascular endothelial growth factor (VEGF) in arterial hypertension. The aim of the study was to determine some markers of vascular function, including VEGF, active renin and prostaglandin E 2 (
Autor:
E. Nachev, Orbetzova M, Georgi Kirilov, I. Atanassova, Krassimir Kalinov, Sabina Zacharieva, R. Shigarminova
Publikováno v:
Scopus-Elsevier
Hormone replacement therapy (HRT) was considered as main prevention of cardiovascular disease (CVD) in postmenopausal women. Mechanisms of vasoprotective effect of this treatment are complex. However, recent data give rise to some uncertainties about
Autor:
M, Orbetsova, Z, Kamenov, G, Kolarov, S, Zakharieva, V, Khristov, I, Atanasova, R, Shigarminova, B, Milcheva, G, Genchev
Publikováno v:
Akusherstvo i ginekologiia. 45(7)
PCOS is a complex disorder with variability of phenotypes, characterized by hyperandrogenic, anovulatory and metabolic components. The later is a result of specific insulin resistant state with compensatory hyperinsulinaemia. Oral hormonal contracept
Autor:
Orbetzova M, Alexander Stoynev, R. Shigarminova, Maria Yaneva, Atanaska Elenkova, E. Nachev, Krassimir Kalinov, Sabina Zacharieva
Publikováno v:
Journal of endocrinological investigation. 27(10)
The aim of the study was to evaluate the circadian blood pressure (BP) pro - files in patients with two forms of Cushing’s syndrome, and to compare them to those in patients with essential hypertension. The study included 100 patients with Cushing
Autor:
Maria M. Orbetzova, Radina Ivanova, E. Nachev, R. Shigarminova, Georgy Dashev, Georgy Kirilov, I. Atanassova, Krassimir Kalinov, Sabina Zacharieva
Publikováno v:
European journal of endocrinology. 150(3)
OBJECTIVES: The aim of the present study was to determine vascular endothelial growth factor (VEGF), prostaglandin E(2) (PGE(2)) and active renin levels in patients with hormonally active adrenal tumours. DESIGN: The study was comprised of 16 patient
Effect of amlodipine and hormone replacement therapy on blood pressure and bone markers in menopause
Autor:
R. Shigarminova, E. Nachev, Sabina Zacharieva, Orbetzova M, A M Borissova, Doncheva N, Zdravko Kamenov, Alexander Stoynev, I. Atanassova
Publikováno v:
Methods and findings in experimental and clinical pharmacology. 25(3)
The aim of this study was to observe the effect of an 8-week treatment with amlodipine, alone or in combination with hormone replacement therapy (HRT), on blood pressure (BP), serum osteocalcin, bone-specific alkaline phosphatase (B-ALP) and urine de
Autor:
S, Zacharieva, G, Kirilov, K, Kalinov, R, Shigarminova, E, Nachev, M, Orbetzova, I, Atanassova
Publikováno v:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 16(6)
Hormone replacement therapy (HRT) was considered as main prevention of cardiovascular disease (CVD) in postmenopausal women. Mechanisms of vasoprotective effect of this treatment are complex. However, recent data give rise to some uncertainties about
Autor:
S, Zacharieva, I, Atanassova, G, Kirilov, K, Kalinov, R, Shigarminova, E, Nachev, N, Aslanova
Publikováno v:
Climacteric : the journal of the International Menopause Society. 5(3)
Mechanisms of the vasoprotective effect of hormone replacement therapy (HRT) are not completely understood, and they may involve direct actions on blood vessels through modulation of endogenous vasoconstrictors and vasodilators. Most studies have foc
Autor:
N. Aslanova, R. Shigarminova, Krassimir Kalinov, E. Nachev, Sabina Zacharieva, Georgi Kirilov, I. Atanassova
Publikováno v:
Scopus-Elsevier
Background: Mechanisms of the vasoprotective effect of hormone replacement therapy (HRT) are not completely understood, and they may involve direct actions on blood vessels through modulation of endogenous vasoconstrictors and vasodilators. Most stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ec950eda2961b6223c4f6b1fa8a45f
http://www.scopus.com/inward/record.url?eid=2-s2.0-0036392871&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0036392871&partnerID=MN8TOARS
Autor:
Valentin Lozanov, Orbetzova M, R. Shigarminova, Atanaska Elenkova, Sabina Zacharieva, Georgi Kirilov, Vanio Mitev
Publikováno v:
Europe PubMed Central
In the present study, we assessed the levels of fasting homocysteine in patients with active Cushing's syndrome using two different assay methods. To determine a possible link between homocysteine and renin-angiotensin-aldosterone system (RAAS), nine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c125c9fe67ddeb122b05f35c15715e58
http://europepmc.org/abstract/med/18597007
http://europepmc.org/abstract/med/18597007